Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


27.01.2025

5 Ann Hematol
4 Blood
1 Bone Marrow Transplant
1 Eur J Haematol
1 Int J Hematol
2 Leuk Lymphoma
2 Leuk Res
2 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Hematol

  1. YIGIT KAYA S, Vatani M, Akil R, Cakir T, et al
    A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient.
    Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06118.
    PubMed         Abstract available

  2. ZHENG J, Zhou Y, Zhao Y, Luo Y, et al
    Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogene
    Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-025-06202.
    PubMed         Abstract available

  3. HIDALGO-GOMEZ G, Tazon-Vega B, Palacio C, Saumell S, et al
    How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia.
    Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06151.
    PubMed         Abstract available

  4. MASUDA Y, Sadato D, Toya T, Hirama C, et al
    Telomere shortening in donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation: a case report.
    Ann Hematol. 2025 Jan 22. doi: 10.1007/s00277-025-06222.
    PubMed         Abstract available

  5. YE Y, Zhao Z, Mo W, Liu W, et al
    Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment.
    Ann Hematol. 2025 Jan 21. doi: 10.1007/s00277-024-06169.
    PubMed         Abstract available


    Blood

  6. CHAPAPRIETA V, Maiques-Diaz A, Nadeu F, Clot G, et al
    Dual Biological Role and Clinical Impact of De Novo Chromatin Activation in Chronic Lymphocytic Leukemia.
    Blood. 2025 Jan 22:blood.2024025396. doi: 10.1182/blood.2024025396.
    PubMed         Abstract available

  7. ALIKARAMI F, Xie HM, Riedel SS, Goodrow H, et al
    GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
    Blood. 2025 Jan 22:blood.2024025761. doi: 10.1182/blood.2024025761.
    PubMed         Abstract available

  8. LYU J, Liu Y, Liu N, Vu H, et al
    CD44-Mediated Metabolic Rewiring is A Targetable Dependency of IDH-Mutant Leukemia.
    Blood. 2025 Jan 22:blood.2024027207. doi: 10.1182/blood.2024027207.
    PubMed         Abstract available

  9. SCHAFER HACKENHAAR F, Refhagen N, Hagleitner MM, van Leeuwen FN, et al
    CpG island methylator phenotype classification improves risk assessment in pediatric T-cell Acute Lymphoblastic Leukemia.
    Blood. 2025 Jan 22:blood.2024026027. doi: 10.1182/blood.2024026027.
    PubMed         Abstract available


    Bone Marrow Transplant

  10. OSHIMA S, Arai Y, Kondo T, Yano S, et al
    Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.
    Bone Marrow Transplant. 2025 Jan 21. doi: 10.1038/s41409-025-02508.
    PubMed         Abstract available


    Eur J Haematol

  11. YANG MM, Singh R, Haugen M, Duff A, et al
    Adherence to 6-Mercaptopurine (6-MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL).
    Eur J Haematol. 2025 Jan 20. doi: 10.1111/ejh.14386.
    PubMed         Abstract available


    Int J Hematol

  12. FENG LS, Li HY, Tang A, Xu ML, et al
    Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia.
    Int J Hematol. 2025 Jan 23. doi: 10.1007/s12185-025-03915.
    PubMed         Abstract available


    Leuk Lymphoma

  13. KRSTEVSKA BOZHINOVIKJ E, Matevska-Geshkovska N, Staninova Stojovska M, Gjorgievska E, et al
    Presence of minimal residual disease determined by next-generation sequencing is not a reliable prognostic biomarker in children with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2025 Jan 22:1-8. doi: 10.1080/10428194.2025.2456100.
    PubMed         Abstract available

  14. CHIN KK, Derkach A, Famulare C, Gupta GK, et al
    HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.
    Leuk Lymphoma. 2025;66:270-278.
    PubMed         Abstract available


    Leuk Res

  15. EPSTEIN-PETERSON ZD, Gurumurthi A, Horwitz SM
    New treatments for adult T-cell leukemia/lymphoma.
    Leuk Res. 2025;149:107642.
    PubMed         Abstract available

  16. YOSHIMITSU M
    Targeted antibody therapy as a treatment strategy for aggressive adult T-cell leukemia/lymphoma.
    Leuk Res. 2025;149:107653.
    PubMed         Abstract available


    Leukemia

  17. TREMBLAY CS, Saw J, Yan F, Boyle JA, et al
    Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia.
    Leukemia. 2025 Jan 23. doi: 10.1038/s41375-024-02491.
    PubMed         Abstract available

  18. LAUWEREINS L, Van Thillo Q, Demeyer S, Mentens N, et al
    TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia.
    Leukemia. 2025 Jan 21. doi: 10.1038/s41375-025-02513.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.